This module enables investors to look at Alexion Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 285.8 M, Cost of Revenue of 258.4 M or Earning Before Interest and Taxes EBIT of 641.6 M, but also many exotic indicators such as Interest Coverage of 9.5352, Long Term Debt to Equity of 0.4077 or Calculated Tax Rate of 53.5497. This module is a perfect complement to use when analyzing Alexion Pharmaceuticals Valuation or Volatility. It can also complement various Alexion Pharmaceuticals Technical models. Check also analysis of Alexion Pharmaceuticals Correlation with competitors.